FBiotechnology UGM – Master of Biotechnology study program at the UGM Postgraduate School again received the opportunity to have a guest lecture from PT. Kalbe Farma, Tbk represented by Dr. Harry Murti. He serves as Head of Process Development at the Stem Cell Processing Laboratory. Previously, he studied post-doctoral program at Hanyang Biomedical Research Institute, South Korea.
PT Kalbe Farma, Tbk is a pharmaceutical company that now has become healthcare. Some of the strategic business units owned are Pharma which is in charge of the production of over-the-counter drugs such as cold, diarrhea, and prescription drugs. In addition, there is Biopharma which is composed of several divisions such as eyecare, consumer health, logistics, and medical devices. Then there is Kalgen DNA which functions to provide diagnostic kits.
